Genta, Inc. (GNTA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genta, Inc. (GNTA)

GNTA 2.240

-2.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John William Anderson who wrote (1643)	9/4/2002 12:14:50 PM
From: John William Anderson	Read Replies (1) of 1870

Genta news: Genta today announced the initiation of a new, multicenter clinical trial with its lead drug, Genasense(TM), in children with cancer. askmerrill.ml.com,{CDF68C20-759B-4274-AC99-E3C2EF855A85},00.html

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next